Beijing Labtech Instruments Co., Ltd. Share Price

Equities

688056

CNE1000043C6

Office Equipment

End-of-day quote Shanghai S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
23.8 CNY +8.58% Intraday chart for Beijing Labtech Instruments Co., Ltd. +14.70% -28.98%

Financials

Sales 2024 * 525M 72.45M 0 Sales 2025 * 596M 82.25M 0 Capitalization 1.6B 221M 0
Net income 2024 * 73M 10.07M - Net income 2025 * 83M 11.45M - EV / Sales 2024 * 3.05 x
Net cash position 2024 * - 0 - Net cash position 2025 * - 0 - EV / Sales 2025 * 2.68 x
P/E ratio 2024 *
21.8 x
P/E ratio 2025 *
19.1 x
Employees 504
Yield 2024 *
0.69%
Yield 2025 *
0.82%
Free-Float 30.69%
More Fundamentals * Assessed data
Dynamic Chart
Beijing Labtech Instruments Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Beijing Labtech Instruments Co., Ltd.'s Equity Buyback Plan announced on February 29, 2024. CI
Beijing Labtech Instruments Co., Ltd. announces an Equity Buyback for CNY 30 million worth of its shares. CI
Beijing Labtech Instruments Co., Ltd. authorizes a Buyback Plan. CI
Beijing Labtech Instruments Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Suzhou Yilite Technology Co., Ltd. announced that it has received CNY 100 million in funding from a group of investors CI
Beijing Labtech Instruments Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Certain A Shares of Beijing Labtech Instruments Co., Ltd. are subject to a Lock-Up Agreement Ending on 2-SEP-2023. CI
Beijing Labtech Instruments Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Beijing Labtech Instruments Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Beijing LabTech Instruments’ 2022 Profit Tanks 33% on COVID-19 Pandemic MT
Beijing Labtech Instruments Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Beijing Labtech Instruments Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Beijing Labtech Instruments Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Beijing Labtech Instruments Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 day+8.58%
1 week+14.70%
Current month-7.64%
1 month-9.78%
3 months-13.61%
6 months-30.85%
Current year-28.98%
More quotes
1 week
20.00
Extreme 20
24.10
1 month
19.80
Extreme 19.8
27.12
Current year
17.71
Extreme 17.71
34.00
1 year
17.71
Extreme 17.71
47.28
3 years
17.71
Extreme 17.71
88.00
5 years
17.71
Extreme 17.71
88.00
10 years
17.71
Extreme 17.71
88.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 68 07/01/02
Chairman 42 29/02/08
Director of Finance/CFO 47 31/05/03
Members of the board TitleAgeSince
Director/Board Member 38 01-25
Director/Board Member 51 24/04/19
Director/Board Member 53 25/05/22
More insiders
Date Price Change Volume
26/04/24 23.8 +8.58% 995,465
25/04/24 21.92 +0.92% 283,093
24/04/24 21.72 +2.21% 233,765
23/04/24 21.25 +2.66% 355,715
22/04/24 20.7 -0.24% 381,280

End-of-day quote Shanghai S.E., April 25, 2024

More quotes
Beijing LabTech Instruments Co Ltd is a China-based company mainly engaged in the research, development, production and sales of experimental analytical instruments. The company also provides customers with the implementation of clean and environmentally friendly laboratory solutions, including the specific implementation of various laboratory businesses such as clean chemical laboratories, laboratory ventilation and renovation projects. The Company has brands such as LabTech, CDS, and Empore. The Company's main products include fully automatic multi-functional high-throughput thermal cracking instrument, fully automatic high-throughput solid phase extraction series instrument, fully automatic nuclide separation instrument series, radioactive element enrichment series and circulating water cooler, etc. Its products are used in food testing, environmental monitoring, drug quality testing, medical diagnosis and other industries.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
23.8
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688056 Stock